Stock listing

Cel-sci Corporation

Selected listing: CVM · AMEX · USD · US

Cel-sci Corporation (NYSE American: CVM), Health Technology. Latest release Aug 17, 2026: CEL-SCI Reports Fiscal Third Quarter 2026 Results.

CVM:AMEXUSDUSUpdated October 3, 2026

Ticker: NYSE American: CVM
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NYSE American
Currency: USD

About Cel-sci Corporation

The company is focused on developing innovative therapies for cancer and other diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

Latest news from Cel-sci Corporation

CEL-SCI Reports Fiscal Third Quarter 2026 Results

August 17, 2026

Cel-Sci: Fiscal Q3 Earnings Snapshot

August 14, 2026

CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer

July 13, 2026

CEL-SCI Announces Closing of Offering

June 16, 2026

CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy

June 16, 2026

All Cel-sci Corporation news →

Research Cel-sci Corporation

Cel-sci Corporation company profile

View the public company page for Cel-sci Corporation on 6ix.

Cel-sci Corporation news

Read company news and market updates connected to Cel-sci Corporation.

Cel-sci Corporation investor events

Find investor webinars, events, and replay context for Cel-sci Corporation.